切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (04) : 323 -327. doi: 10.3877/cma.j.issn.2095-3224.2016.04.009

所属专题: 经自然腔道取标本手术学 文献

论著

结直肠癌NOSE术的近期效果及对机体细胞免疫功能影响的研究
胡俊杰1, 魏少忠1, 熊治国1,(), 杨伯君1   
  1. 1. 430071 武汉,湖北省肿瘤医院胃肠外科;湖北省结直肠癌临床研究中心
  • 收稿日期:2016-04-23 出版日期:2016-08-25
  • 通信作者: 熊治国

Effect of laparoscopic resection with natural orifice specimen extraction on short-term outcomes and cellular immunity for colorectal cancer

Junjie Hu1, Shao zhong Wei1, Zhiguo Xiong1,(), Bojun Yang1   

  1. 1. Department of Gastrointestinal Surgery, Hubei Colorectal Cancer Clinical Research Center, Hubei Cancer Hospital, Wuhan 430071, China
  • Received:2016-04-23 Published:2016-08-25
  • Corresponding author: Zhiguo Xiong
  • About author:
    Corresponding author: Xiong Zhiguo, Email:
引用本文:

胡俊杰, 魏少忠, 熊治国, 杨伯君. 结直肠癌NOSE术的近期效果及对机体细胞免疫功能影响的研究[J/OL]. 中华结直肠疾病电子杂志, 2016, 05(04): 323-327.

Junjie Hu, Shao zhong Wei, Zhiguo Xiong, Bojun Yang. Effect of laparoscopic resection with natural orifice specimen extraction on short-term outcomes and cellular immunity for colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(04): 323-327.

目的

探讨腹腔镜结直肠癌标本经自然腔道取出手术(natural orifice specimen extraction,NOSE)的近期效果及对患者细胞免疫功能的影响。

方法

收集湖北省肿瘤医院2014年9月至2016年3月期间接受腹腔镜结直肠癌根治手术的89例患者的临床病理资料,其中标本经肛门取出的腹腔镜结直肠癌根治术患者31例(NOSE组),传统腹腔镜辅助结直肠癌根治术患者58例(LAP组),比较两组患者手术的近期效果及细胞免疫功能指标变化。

结果

两组患者术前的各临床指标及细胞免疫功能指标相似,差异均无统计学意义(均P>0.05)。患者手术时间、手术并发症发生率及淋巴结检出数目两组差异均无统计学意义(均P>0.05)。NOSE组术后疼痛评分(2.8±0.9分)显著少于LAP组(3.7±1.2分),(t=3.766,P<0.001)。NOSE组和LAP组患者术后排气时间分别为2.6±0.8 d和3.3±0.8 d,(t=4.427,P<0.001)。NOSE组患者术后住院时间较LAP组短,两组分别为7.8±4.3 d和10.3±5.4 d,(t=2.213,P=0.030)。NOSE组与LAP组患者术后第3天CD4T细胞与术前相比均有显著下降(均P<0.05),且LAP组术后第3天CD4T细胞比例更低,两组差异有统计学意义(t=4.017,P=0.002)。术后第3天CD8T细胞及CD4 /CD8与术前相比,LAP组下降明显,差异有统计学意义(均P<0.05),而NOSE组下降不明显(均P>0.05)。两组患者术后CRP水平均显著升高(均P<0.05),且LAP组升高更加明显,两组术后第3天、第6天CRP水平差异均有统计学意义,均P<0.05。

结论

结直肠癌NOSE术与传统腹腔镜辅助手术相比,具有更加优越的微创效果,对患者细胞免疫功能影响更小。

Objective

This study aimed to evaluate the effect of laparoscopic resection with natural orifice specimen extraction (NOSE) on short-term outcomes and cellular immunity for colorectal cancer.

Methods

From September 2014 to March 2016, data of 89 colorectal cancer patients who underwent laparoscopic resection were reviewed. All included thirty-one patients underwent laparoscopic resection with NOSE (NOSE group), and fifty-eight patients underwent traditional laparoscopic-assisted resection (LAP group). Short-term outcomes and cellular immunity of the patients in the two groups were compared.

Results

The baseline characteristics of the two groups were similar (P>0.05). The two groups did not differ in operating time, perioperative complications and the number of lymph node harvest (P>0.05). Pain score after operation in the NOSE group (2.8±0.9) was significantly lower than those in the LAP group (3.7±1.2) (t=3.766, P<0.001). Times to first flatus were 2.6±0.8 days and 3.3±0.8 days in NOSE group and LAP group, respectively (t=4.427, P<0.001). Postoperative hospital stay in NOSE group were 7.8±4.3 days and 10.3±5.4 days in LAP group, (t=2.213, P=0.030). CD4+ T cell counts on the 3rd day after operation were significantly lower than those on the day before operation in both groups,and there were significant differences in CD4+ T cell counts on the 3rd day after operation between two groups (t=4.017, P=0.002). CD8+ T cell counts and CD4+ /CD8+ were significantly lower than those on the day before operation in LAP group(P<0.05) but not in NOSE group (P>0.05). CRP level was significantly higher after surgery in both group(P<0.05), and CRP level in the LAP group was significantly higher than that of the NOSE group on the 3rd and the 6th day after surgery (P<0.05).

Conclusion

Compared with traditional laparoscopic-assisted resection, NOSE has better effect of minimally invasive and smaller effect on cellular immunity for colorectal cancer.

表1 89例结直肠癌患者的临床病理资料表
图1 NOSE手术标本取出及钉砧头置入关键步骤图:A肛门置入保护套后将标本拖出(方法一);B外翻拖出直肠后,直视下离断肿瘤远端肠管(方法二);C、D采用荷包缝合将吻合器钉砧头固定于近端肠管
表2 NOSE组与LAP组患者的手术结果比较
图2 NOSE组与LAP组患者细胞免疫指标及CRP水平比较,*为同术前相比,P<0.05
[1]
王锡山.结直肠肿瘤类-NOTES术之现状及展望[J].中华结直肠疾病电子杂志, 2015, 4(4):11-16.
[2]
胡俊杰,周志祥. 直肠癌NOSE手术应用技术及规范[J].实用肿瘤杂志, 2015, 30(3):209-213.
[3]
Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial[J]. Lancet, 2005, 365(9472):1718-1726.
[4]
Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial[J]. Lancet Oncol, 2014, 15(7):767-774.
[5]
Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer[J]. N Engl J Med, 2015, 372(14):1324-1332.
[6]
Cahill R, Lindsey I, Cunningham C. NOTES for colorectal neoplasia–surgery through the looking glass[J]. Gut, 2009, 58(8):1168-1169.
[7]
Franklin ME Jr, Liang S, Russek K. Integration of transanal specimen extraction into laparoscopic anterior resection with total mesorectal excision for rectal cancer: A consecu-tive series of 179 patients[J]. Surg Endosc, 2013, 27(1):127-132.
[8]
Menges P, Kessler W, Kloecker C, et al. Surgical trauma and postoperative immune dysfunction[J]. Eur Surg Res, 2012, 48(4):180-186.
[9]
Schreiber RD, Old LJ, Smyth MJ.Cancer Immunoediting: Integrating Immunity′s Roles in Cancer Suppression and Promotion[J]. Science, 2011, 331(6024):1565-1570.
[10]
Ali AA, McMillan DC, Matalka II, et al.Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer[J]. Eur J Surg Oncol, 2004, 30(3):292-295.
[11]
Joosten SA, Ottenhoff TH. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination[J]. Hum Immunol, 2008, 69(11):760-770.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?